Porton Biopharma Competitors and Similar CompaniesClear all

Porton Biopharma's competitors and similar companies include Teva Pharmaceuticals, India Globalization Capital, KSQ Therapeutics and LifeMine Therapeutics.
Porton Biopharma
Porton Biopharma
Porton Biopharma is a pharmaceutical development and manufacturing company.
Teva Pharmaceuticals
Teva Pharmaceuticals
Teva Pharmaceuticals is a global pharmaceutical company.
India Globalization Capital
India Globalization Capital
India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.
KSQ Therapeutics
KSQ Therapeutics
KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies.
LifeMine Therapeutics
LifeMine Therapeutics
LifeMine Therapeutics is a pharmaceutical company that develops fungi-based therapies.
Founding Date
Founding Date
2015
Founding Date
1901
Founding Date
2005
Founding Date
2015
Founding Date
2017
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Private
Tags
Locations
Locations
Salisbury, GB HQ
Salisbury, GB
Selby, GB
Locations
Petah Tikva, IL HQ
Villa Adelina, AR
Macquarie Park, AU
Minsk, BY
Antwerpen, BE
Sao Paulo, BR
Dupnica, BG
see more
Locations
Bethesda, US HQ
Locations
Cambridge, US HQ
Locations
Cambridge, US HQ
Basel, CH
Gloucester, US
Employees
Employees
1506% increase
Employees
37,000
Employees
50150% increase
Employees
862% increase
Employees
943% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
20.8 b
Valuation ($)
30 m
Valuation ($)
N/A
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$16.5b (FY, 2024)
Revenue (est.)
$1.3m (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$8.5b (FY, 2024)
Cost of goods
$612k (FY, 2024)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$8.1b (FY, 2024)
Gross profit
$733k (FY, 2024)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
($2b) (FY, 2024)
Net income
($13m) (FY, 2024)
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 80m (over 6 years ago)
Latest funding round
$ 55m (over 7 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 358m
Total funding raised
N/A
Total funding raised
$ 156m
Total funding raised
$ 55m
For sources of this data, please see the company profile

View Company Profiles

Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,000

Teva Pharmaceuticals is a global pharmaceutical company.

View company
India Globalization Capital
HQ
Bethesda, US
Employees
50

India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.

View company
KSQ Therapeutics
HQ
Cambridge, US
Employees
86↑ 2% increase

KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies.

View company
LifeMine Therapeutics
HQ
Cambridge, US
Employees
94↓ 3% decrease

LifeMine Therapeutics is a pharmaceutical company that develops fungi-based therapies.

View company